Ireland
--:--IST
Latest
Airmid Éireann 1.4 Puts Irish Pharma Data in Global Context Northern Ireland Phone Switch-Off: Check Medical Devices Irish Medtech Calls for MDR and IVDR Reform at Galway Event Clonmel Healthcare Launches Mabelle Menocare Supplements HealthSpan Partners to Acquire Irish GP Group Centric Health Outpatient Waiting List Reaches 692,524, Up 10.5% in a Year Airmid Éireann 1.4 Puts Irish Pharma Data in Global Context Northern Ireland Phone Switch-Off: Check Medical Devices Irish Medtech Calls for MDR and IVDR Reform at Galway Event Clonmel Healthcare Launches Mabelle Menocare Supplements HealthSpan Partners to Acquire Irish GP Group Centric Health Outpatient Waiting List Reaches 692,524, Up 10.5% in a Year
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Nantes
Clinical trial register · France

Clinical Trials in Nantes, 2026

Every study on the ClinicalTrials.gov registry that lists a site in France and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 9697 matching records held by the registry are in this view. Synced 26 Oct 2026, 03:20 UTC
9697
Studies in scope
all four open statuses
6025
Recruiting now
open to new participants
1033
Lead sponsors
across recruiting studies
Top sites
Paris 64 Bordeaux 62 Montpellier 61 Lyon 60 Marseille 58
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
Nantes University Hospital176 Janssen Research & Development, LLC35 AstraZeneca27 Novartis Pharmaceuticals25 Sanofi17 Clear sponsor filter
Site location
Paris64 Bordeaux62 Montpellier61 Lyon60 Marseille58
All 106 locations
Target enrolment
to

Trials with a site in Nantes

27 of 9697 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in France
Start
Recruiting
AstraZeneca
Phase 3
750
Lille, Nantes, Paris, Toulouse
2026-09-24
Recruiting
Roll-over Study for Participants Who Have Completed a Previous Clinical Study With Benralizumab (Fasenra) and Benefit From Continued Treatment
NCT07444567Asthma, Eosinophilic Granulomatosis With Polyangiitis (EGPA), Hypereosinophilic Syndrome (HES)
DrugsFasenra·Benralizumab
AstraZeneca
Phase 3
230
Bron, Marseille, Montpellier, Nantes, Paris, Pessac, Suresnes
2026-07-24
Recruiting
AstraZeneca
Phase 3
750
Lille, Nantes, Paris, Poitiers, Toulouse
2026-06-26
Recruiting
AstraZeneca
Phase 2
43
Bordeaux, Créteil, Lyon, Nantes, Nîmes
2026-03-28
Recruiting
AstraZeneca
Phase 3
508
Lille, Nantes, Paris, Pierre-Bénite, Poitiers, Toulouse
2026-02-23
Recruiting
AstraZeneca
Phase 2
230
Lyon, Montpellier, Nantes, Nîmes, Paris, Tours
2025-12-10
Recruiting
A Platform Study in Non-Small Cell Lung Cancer (NSCLC)
NCT06996782Advanced or Metastatic Non-small Cell Lung Cancer
DrugsRamucirumab·Rilvegostomig·Nab-paclitaxel·Pemetrexed
AstraZeneca
Phase 1/2
152
Bordeaux, Dijon, Limoges, Marseille, Nantes, Nice, Paris
2025-11-24
Recruiting
AstraZeneca
Phase 3
1,220
Clichy, Lille, Lyon, Montpellier, Nantes, Nice, Pessac, Rennes
2025-05-06
Active, closed
AstraZeneca
Phase 3
181
Le Kremlin-Bicêtre, Marseille, Nantes, Pierre-Bénite, Poitiers, Toulouse
2024-12-03
Active, closed
AstraZeneca
Phase 3
768
Bordeaux, Caen, Lille, Montpellier, Nantes, Paris, Pessac, Toulon Armees
2024-10-04
Active, closed
AstraZeneca
Phase 3
339
Bois-Guillaume, Dijon, Lyon, Montivilliers, Nantes, Paris, Poitiers, Toulouse
2024-06-29
Active, closed
AstraZeneca
Phase 3
594
Besançon, Brest, Lille, Lyon, Nantes
2024-03-04
Recruiting
AZD0486 as Monotherapy in B-cell Acute Lymphoblastic Leukaemia
NCT06137118B-cell Acute Lymphoblastic Leukemia (B-ALL)
DrugSurovatamig
AstraZeneca
Phase 1/2
255
Caen, Marseille, Nantes, Paris, Pierre-Bénite, Toulouse
2023-12-29
Recruiting
AstraZeneca
Phase 1/2
226
Lille, Nantes
2023-12-05
Active, closed
AstraZeneca
Phase 3
594
Angers, Clamart, Clermont-Ferrand, Créteil, Lyon, Montpellier, Nantes, Paris
2022-09-15
Active, closed
AstraZeneca
Phase 3
760
Angers, Clichy, Créteil, Montpellier, Nantes, Nice, Paris, Strasbourg
2022-03-28
Active, closed
AstraZeneca
Phase 3
454
Bordeaux, Dijon, Le Mans, Lyon, Marseille, Nantes, Toulouse, Villejuif
2021-10-28
Active, closed
AstraZeneca
Phase 3
957
Avignon, Besançon, Brest, Dijon, Lyon, Montpellier, Nantes, Nice
2020-11-17
Active, closed
AstraZeneca
Phase 3
140
Dijon, Marseille, Montpellier, Nantes, Paris, Suresnes, Toulouse
2019-10-29
Active, closed
AstraZeneca
Phase 3
724
Bron, Dijon, Lyon, Nantes, Pierre-Bénite, Toulouse, Villejuif
2019-03-06
Active, closed
AstraZeneca
Phase 2
367
Dijon, Marseille, Nantes, Paris, Rennes
2019-01-09
Active, closed
AstraZeneca
Phase 3
1,407
Besançon, Bordeaux, Limoges, Lyon, Marseille, Nantes, Paris, Saint-Herblain
2019-01-04
Active, closed
AstraZeneca
Phase 2
528
Bordeaux, Nantes, Paris, Villejuif
2017-12-18
Active, closed
AstraZeneca
Phase 3
1,324
Clichy, Lille, Marseille, Montpellier, Nancy, Nantes, Nice, Pessac
2017-10-11
Active, closed
AstraZeneca
Phase 1/2
264
Bordeaux, Caen, Clermont-Ferrand, Dijon, Marseille, Nantes, Paris, Pierre Benit Cedex
2016-03-17
Active, closed
Olaparib Treatment in BRCA Mutated Ovarian Cancer Patients After Complete or Partial Response to Platinum Chemotherapy
NCT01874353Platinum Sensitive, BRCA Mutated, Relapsed Ovarian Cancer, Following Complete or Partial Response to Platinum Based Chemotherapy
DrugOlaparib
AstraZeneca
Phase 3
327
Bordeaux, Caen, Lyon, Nantes, Paris, Pierre-Bénite, Saint-Cloud, Toulouse
2013-09-03
Active, closed
Olaparib Maintenance Monotherapy in Patients With BRCA Mutated Ovarian Cancer Following First Line Platinum Based Chemotherapy.
NCT01844986Newly Diagnosed, Advanced Ovarian Cancer, FIGO Stage III-IV, BRCA Mutation
DrugOlaparib
AstraZeneca
Phase 3
450
Bordeaux, Caen, Lyon, Nantes, Paris, Vandœuvre-lès-Nancy, Villejuif
2013-08-26
Rows per page Showing 1–27 of 27
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a French investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 27 October 2026. https://priyalifescience.com/clinical-trials-france/city/nantes

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in France and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 9,697 studies in total at the last sync on 26 Oct 2026, 03:20 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 27 of those studies with a site in Nantes that also match the filters currently applied.

How many clinical trials are recruiting in Nantes?

10 of the 27 studies on this page are recruiting new participants as of the 26 Oct 2026, 03:20 UTC sync. A further 0 have not yet opened recruitment, 17 are active but closed to new participants, and 0 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Nantes), 27 studies
PhaseStudiesRecruitingShare
Phase 319570.4%
Phase 1/24314.8%
Phase 24214.8%

Most active sponsors

Lead sponsors with the most studies (Nantes)
Lead sponsorStudiesRecruiting
AstraZeneca2710
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.